Interests and current limits of MALDI-TOF in clinical bacteriology

被引:0
|
作者
Degand, N. [1 ]
Ruimy, R. [2 ,3 ,4 ]
机构
[1] CHU Nice, Hop Archet 2, Bacteriol Lab, F-06202 Nice 3, France
[2] Hop Bichat Claude Bernard, AP HP, Hop Univ Paris Nord Val de Seine, Lab Bacteriol, F-75018 Paris, France
[3] Univ Paris 07, EA 3964, UFR Med Paris Diderot Paris 7, F-75877 Paris 18, France
[4] Hop Bichat Claude Bernard, Serv Biol Med, F-75877 Paris, France
关键词
MALDI-TOF; Mass spectrometry; Bacterial identification; Positive blood culture; Antibiotic resistance; Carbapenemase detection; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ASSISTED-LASER-DESORPTION/IONIZATION; RAPID IDENTIFICATION; ROUTINE IDENTIFICATION; STAPHYLOCOCCUS-AUREUS; CULTURE-MEDIA; MYCOBACTERIA; REVOLUTION; SAMPLES;
D O I
10.1016/j.antinf.2012.07.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Until the early 2000s, in the clinical microbiology laboratories, the bacterial identification was based mainly on the biochemical analysis of phenotypic characters whose interpretation required expertise. In most cases, the results was obtained after more than 18 h. When it was taken in default, the identification was mainly obtained by molecular biology analysis such as 16S rDNA sequences. For nearly 5 years, using MALDI-TOF mass spectrometry machine revolutionized bacterial identification in clinical bacteriology laboratories. From bacterial colonies, the results of reliable identifications are easily obtained in less than 5 minutes. These advantages have greatly contributed to its success. When a laboratory is equipped by this device, the bulk of the identifications are provided by this new approach. The objective of this review is to analyze the reasons of the success of MALDI-TOF in clinical bacteriology, to know its present limitations and new applications. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [1] Advancing MALDI-TOF MS applications in anaerobic bacteriology
    Nagy, Elisabeth
    Schuetz, Audrey
    [J]. ANAEROBE, 2018, 54 : 189 - 190
  • [2] Current status of MALDI-TOF mass spectrometry in clinical microbiology
    Hou, Tsung-Yun
    Chuan Chiang-Ni
    Teng, Shih-Hua
    [J]. JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (02) : 404 - 414
  • [3] MALDI-TOF/TOF
    不详
    [J]. SCIENTIST, 2005, 19 (16): : 40 - 41
  • [4] MALDI-TOF
    Chakrabarti, A.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 26 - 26
  • [5] Sensitivity of MALDI-TOF and TOF-TOF: Current status and prospects for improvement
    Vestal, Marvin L.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [6] Applications of MALDI-TOF technology in clinical microbiology
    Suarez, S.
    Nassif, X.
    Ferroni, A.
    [J]. PATHOLOGIE BIOLOGIE, 2015, 63 (01): : 43 - 52
  • [7] MALDI-TOF imaging [MALDI-TOF-Bildgebung]
    Kriegsmann J.
    Casadonte R.
    Zweynert F.
    Kriegsmann M.
    Otto M.
    Deininger S.
    [J]. Zeitschrift für Rheumatologie, 2013, 72 (7) : 724 - 728
  • [8] MALDI-TOF imaging
    Kriegsmann, J.
    Casadonte, R.
    Zweynert, F.
    Kriegsmann, M.
    Otto, M.
    Deininger, S.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (07): : 724 - 728
  • [9] MALDI-TOF MS in the Microbiology Laboratory: Current Trends
    Schubert, Soeren
    Kostrzewa, Markus
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2017, 23 : 17 - 20
  • [10] IS MALDI-TOF WORTH IT? THE IMPACT OF MALDI-TOF ON PATIENTS WITH POSITIVE BLOOD CULTURES
    Evans, Andree
    Hincke, Michelle
    Allen, Matt
    Auckland, Cressida
    [J]. JOURNAL OF INFECTION, 2013, 67 (04) : 347 - 347